| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/06/2003 | CA2458844A1 Immobilization of biological molecules onto surfaces coated with monolayers |
| 03/06/2003 | CA2458640A1 Diagnosis, prevention and treatment of cancer |
| 03/06/2003 | CA2458627A1 Human cdr-grafted antibody and antibody fragment thereof |
| 03/06/2003 | CA2458622A1 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 03/06/2003 | CA2458575A1 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy |
| 03/06/2003 | CA2458574A1 Reagents and methods for smooth muscle therapies |
| 03/06/2003 | CA2458565A1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain |
| 03/06/2003 | CA2458561A1 Yeast membrane protein expression system and its application in drug screening |
| 03/06/2003 | CA2458559A1 Gene of novel corynebacterium diphtheriae antigen |
| 03/06/2003 | CA2458506A1 Wild-type ras as a cancer therapeutic agent |
| 03/06/2003 | CA2458445A1 Extracellular messengers |
| 03/06/2003 | CA2458443A1 Bioadhesive compositions and methods for enhanced mucosal drug absorption |
| 03/06/2003 | CA2458381A1 Transmembrane protein differentially expressed in cancer |
| 03/06/2003 | CA2458236A1 Gpi-anchored cytokines |
| 03/06/2003 | CA2458228A1 Molecular interaction sites of 16s ribosomal rna and methods of modulating the same |
| 03/06/2003 | CA2458227A1 Method and device for integrated protein expression, purification and detection |
| 03/06/2003 | CA2458226A1 Improved nitroreductase enzymes |
| 03/06/2003 | CA2458224A1 A universal light-switchable gene promoter system |
| 03/06/2003 | CA2458205A1 Molecular interacting sites of 23s ribosomal rna and methods of modulating the same |
| 03/06/2003 | CA2458202A1 Estrogen receptor alpha variants and methods of detection thereof |
| 03/06/2003 | CA2458187A1 Method for producing vitamin b12 |
| 03/06/2003 | CA2457915A1 Novel human proteases and polynucleotides encoding the same |
| 03/06/2003 | CA2457903A1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 03/06/2003 | CA2457890A1 Vaccine using papillomavirus e proteins delivered by viral vector |
| 03/06/2003 | CA2457888A1 Fluorescent multiplex hpv pcr assays using multiple fluorophores |
| 03/06/2003 | CA2457879A1 Modulators of bone homeostasis identified in a high-throughput screen |
| 03/06/2003 | CA2457807A1 Ashbya gossypii enzymes |
| 03/06/2003 | CA2457779A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 03/06/2003 | CA2457514A1 Mycoplasma bovis challenge model, methods for administering m.bovis and methods for inducing pneumonic lung lesions |
| 03/06/2003 | CA2457479A1 In planta transformation by embryo imbibition of agrobacterium |
| 03/06/2003 | CA2457477A1 Self-processing plants and plant parts |
| 03/06/2003 | CA2457474A1 Method and apparatus for three label microarrays |
| 03/06/2003 | CA2456828A1 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton |
| 03/06/2003 | CA2454609A1 Reverse breeding |
| 03/06/2003 | CA2446547A1 Combinations of genes for producing seed plants exhibiting modulated reproductive development |
| 03/06/2003 | CA2421442A1 Host cells for packing a recombinant adeno-associated virus (raav), method for the production and use thereof |
| 03/05/2003 | EP1288835A1 A method for defining gene hunting studies |
| 03/05/2003 | EP1288661A1 Method for examining wt1-related disease |
| 03/05/2003 | EP1288314A2 Real-time gene quantification with internal standards |
| 03/05/2003 | EP1288312A2 Method for determining quinolone resistance of tubercle bacilli |
| 03/05/2003 | EP1288311A2 Method for testing small pharmaceutically active molecules in the activation of Pax4 and production of insulin producing beta-cells |
| 03/05/2003 | EP1288310A1 Use of SNPs of MCH-R for identifying genetic disorders in maintaining the normal body weight |
| 03/05/2003 | EP1288308A1 A method for the determination of multiple analytes |
| 03/05/2003 | EP1288307A1 Use of fructose-1,6-bisphosphate aldolase for identifying new fungicidal substances |
| 03/05/2003 | EP1288304A2 Self-assembled, defective, non-self-propagating viral particles |
| 03/05/2003 | EP1288303A1 Inducible expression systems employing PPAR transcriptional activators |
| 03/05/2003 | EP1288302A1 Rice regulatory sequences for gene expression in defined wheat tissue |
| 03/05/2003 | EP1288301A1 Plant-derived resistance gene |
| 03/05/2003 | EP1288300A1 Plasmid to be used in chromosome recombination of escherichia coli |
| 03/05/2003 | EP1288299A2 TRNA synthetase |
| 03/05/2003 | EP1288298A2 TRNA synthetase from Staphylococcus aureus |
| 03/05/2003 | EP1288297A1 Regulation of mt1-mmp activity |
| 03/05/2003 | EP1288296A2 Method and reagent for inhibiting HBV viral replication |
| 03/05/2003 | EP1288295A2 Use of mutated recognition sites for multiple successive recombinase-mediated recombinations in a genetic system |
| 03/05/2003 | EP1288294A2 Recombinant Candida rugosa lipases |
| 03/05/2003 | EP1288229A2 Transgenic non human animals capable of producing heterologous antibodies |
| 03/05/2003 | EP1288227A1 Coactivator of nuclear receptors |
| 03/05/2003 | EP1288222A1 Peptidic compounds selectively binding to P-selectin |
| 03/05/2003 | EP1287883A2 Coating composition and random array of microspheres |
| 03/05/2003 | EP1287830A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 03/05/2003 | EP1287404A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method |
| 03/05/2003 | EP1287364A2 Diagnostics and therapeutics for macular degeneration-related disorders |
| 03/05/2003 | EP1287362A2 Compositions and methods for modulating tumor specific expression |
| 03/05/2003 | EP1287361A2 Surface for the immobilisation of ligands |
| 03/05/2003 | EP1287354A2 Assay techniques based on growth stage dependent expression in c. elegans |
| 03/05/2003 | EP1287353A2 Compound screens relating to insulin deficiency or insulin resistance |
| 03/05/2003 | EP1287336A1 Improved imaging spr apparatus |
| 03/05/2003 | EP1287166A1 Determination of nucleotide sequence variations through limited primer extension |
| 03/05/2003 | EP1287164A2 A filter element for use in separation of biomaterials from solid contaminants |
| 03/05/2003 | EP1287163A1 Method for attaching oligonucleotide to solid support and the oligonucleotide array prepared by the method thereof |
| 03/05/2003 | EP1287161A2 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same |
| 03/05/2003 | EP1287157A1 Protein markers for pharmaceuticals and related toxicity |
| 03/05/2003 | EP1287154A1 Charge-switch nucleotides |
| 03/05/2003 | EP1287153A2 Methods and compositions for efficient gene transfer using transcomplementary vectors |
| 03/05/2003 | EP1287152A2 Human-bovine chimeric respiratory syncytial virus vaccines |
| 03/05/2003 | EP1287151A2 Method of using dna episomes to suppress gene expression in plants |
| 03/05/2003 | EP1287150A2 Method of using dna episomes to suppress gene expression in plants |
| 03/05/2003 | EP1287149A2 High level production of p-hydroxybenzoic acid in green plants |
| 03/05/2003 | EP1287148A2 Insect resistant transgenic plants expressing biotin-binding protein gene |
| 03/05/2003 | EP1287147A2 Immunotoxin fusion proteins and means for expression thereof |
| 03/05/2003 | EP1287146A2 Cold sensitive mutant dna polymerases |
| 03/05/2003 | EP1287145A2 The non-mevalonate isoprenoid pathway |
| 03/05/2003 | EP1287144A2 Bacterial insecticidal proteins |
| 03/05/2003 | EP1287143A2 Corynebacterium glutamicum nucleotide sequences coding for the glbo gene |
| 03/05/2003 | EP1287142A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
| 03/05/2003 | EP1287141A2 Extracellular messengers |
| 03/05/2003 | EP1287140A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 03/05/2003 | EP1287139A2 Synthetic spider silk proteins and the expression thereof in transgenic plants |
| 03/05/2003 | EP1287138A1 Novel g-protein coupled receptor |
| 03/05/2003 | EP1287137A2 REGULATION OF HUMAN $g(a)1A?ADRENERGIC RECEPTOR-LIKE G PROTEIN-COUPLED RECEPTOR |
| 03/05/2003 | EP1287136A1 Modified chemokine receptor ccr-3 and assay |
| 03/05/2003 | EP1287135A2 Regulation of human follicle stimulating hormone-like g protein-coupled receptor |
| 03/05/2003 | EP1287134A2 The human voltage-gated sodium channel beta-1a subunit and methods of use |
| 03/05/2003 | EP1287133A2 Regulation of human dopamine-like g protein-coupled receptor |
| 03/05/2003 | EP1287132A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/05/2003 | EP1287131A2 Regulator of g protein signalling (rgs8) |
| 03/05/2003 | EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 03/05/2003 | EP1287128A2 Myc targets |
| 03/05/2003 | EP1287127A2 Regulation of human histamine h2-like g protein-coupled receptor |
| 03/05/2003 | EP1287126A1 Ligands specific for an isoform of the prion protein |